Intercept Pharmaceuticals

Insider buying can be an encouraging signal for potential investors. Insiders at a biotech took advantage of a secondary offering this past week. Several retailers saw notable insider purchases as well. Conventional wisdom says that insiders and 10-percent owners only buy shares of a...

U.S. stocks were marginally lower, as investors and traders may be waiting on the sidelines for further clarity on geopolitical tension. Volume was lighter than usual, as the composite volume on the New York Stock Exchange was 2.2 billion right before the closing bell. Typically, 2.1 billion...

Cowen analysts recently released a research report that focused on biotech stocks with promising Phase 3 data leading into the U.S. Food and Drug Administration (FDA) approval process. ACADIA Pharmaceuticals (NASDAQ: ACAD), Alexion Pharmaceuticals (NASDAQ: ALXN), InterMune (NASDAQ: ITMN) and...

U.S. stocks were little changed despite an ADP jobs report showing better-than-expected numbers. The ADP report comes ahead of the non-farm payrolls due on Thursday. Analysts are expecting the payrolls to confirm 212,000 jobs were added in June. The markets will close at 1:00 p.m. on Thursday...

U.S. stocks rose to start off the holiday-filled shortened trading week on a positive note as investors found plenty of reason to be optimistic on retail sales which jumped the most since 2012. Investors were also encouraged by Citigroup's better than expected earnings which eased investor...

U.S. stocks ended the week on a sour note as investors continue to sell many momentum names. Not helping the bull case was the much anticipated Jobs report number which failed to "wow" the market, coming in relatively in-line with expectations. The Dow suffered a triple digit point loss and...

U.S. stocks rose as investors focused on positive economic data rather than the tense situation in Ukraine. Economic reports showed that U.S. industrial production rose in February. President Obama imposed sanctions against Russian and Crimea officials following an election on Sunday which...

Here's a look at the top tickers trending on StockTwits.com. Intercept Pharmaceuticals: Phase III trial update Intercept Pharmaceuticals (NASDAQ: ICPT) announced hat its liver disease drug obeticholic acid (OCA) for primary biliary cirrhosis has been successful in its POISE phase III clinical...

Shares of the following exchange traded funds are trading more than 20 percent higher than 90 days ago, and they are within 10 percent of their 52-week highs. This set of ETFs provides a peek at areas of investor interest during and after the holiday shopping season, as uncertainty over the...

The market picked up where it left off Tuesday and recorded a second straight day of strong gains. The Dow posted a triple digit point gain while the S&P 500 and Nasdaq all gained as the Federal Reserve's Beige Book indicated that economic growth remained healthy in most U.S. regions. The...

Major indices reversed Monday's losses and posted strong gains following a better than expected retail sales report and a luke-warm start to earnings season. Related: Stocks Higher, But Dollar Indecisive After Retail Sales Release Philidalphia's Fed chief Charles Plosser said that he wants QE...

Investors and traders were in clear selling mode today ahead of a very busy week of earnings. The Dow suffered a triple digit point loss while the S&P 500 and Nasdaq suffered losses of more than one percent. There were no key economic data releases today. Related: Earnings Expectations For...